Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02095093
Other study ID # Intellijoint HIP
Secondary ID
Status Recruiting
Phase N/A
First received November 8, 2013
Last updated March 20, 2014
Start date March 2014

Study information

Verified date March 2014
Source Mount Sinai Hospital, Canada
Contact Jesse I Wolfstadt, MD
Phone 4167277374
Email jesse.wolfstadt@mail.utoronto.ca
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Leg length discrepancies following total hip arthroplasty have been associated with nerve palsies, gait abnormalities, and lower back pain. Leg length discrepancies are related to poorer functional outcomes and patient dissatisfaction. Failure to restore femoral offset following total hip arthroplasty has been linked to decreased range of motion and abductor muscle strength, impingement, limping, higher dislocation rates, increased polyethylene wear, and loosening of implants. Computer navigation has shown to improve the accuracy of leg length and hip offset during total hip arthroplasty. The investigators research objective is to prove the accuracy of the Intellijoint HIP™ system for determining leg length and hip offset. The investigators hypothesis was that Intellijoint HIP™, an imageless intraoperative intelligent instrument, could improve the accuracy of leg length and hip offset during primary total hip arthroplasty. The investigators plan to study this hypothesis in humans by comparing the leg length and hip offset discrepancies produced with Intellijoint HIP™ to the standard at the investigators institution, which is a pin and outrigger system.


Recruitment information / eligibility

Status Recruiting
Enrollment 128
Est. completion date
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Any patient who is undergoing a primary total hip arthroplasty at Mount Sinai Hospital.

Exclusion Criteria:

- Pre-operative flexion contracture >30°, infection, or inability to achieve rigid fixation of instruments intra-operatively.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Device:
Intellijoint HIP
Intellijoint HIP is an intra-operative, imageless intelligent instrument used to provide real-time information to surgeons about leg length and hip offset changes during total hip replacement surgery.
Outrigger
The outrigger is a pin and caliper device that is used to assess leg length and offset during total hip arthroplasty. It is the current standard of care at Mount Sinai Hospital.

Locations

Country Name City State
Canada Mount Sinai Hospital Torono Ontario

Sponsors (1)

Lead Sponsor Collaborator
Mount Sinai Hospital, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of leg length Standard post-operative anteroposterior pelvis radiographs will be used to assess the leg length discrepancy 6 weeks post-op No
Primary Accuracy of Hip Offset Standard post-operative anteroposterior pelvis radiographs will be used to assess the hip offset restoration 6 weeks post-op No
Secondary Time of surgery We will measure the skin-to-closure time for each surgery to assess additional time, if any, added to procedure when using PelvAssist. Measured at the time of surgery No
Secondary Harris Hip Score We will measure the Harris Hip Scores at 6 weeks and 1 year post-op. 1 year No
Secondary Dislocation Rates We will record the dislocation rates at one year following surgery. 1 Year No
Secondary Oxford Hip Scores 6 weeks and 1 year post-op No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03326804 - H1 Hip Resurfacing Arthroplasty
Not yet recruiting NCT04257682 - Regional Anesthesia in Total Hip and Knee Arthroplasty Phase 4
Completed NCT02876120 - The STavanger osteoARThritis Study N/A
Terminated NCT02231567 - Neurocognitive Rehabilitation After Hip Replacement N/A
Recruiting NCT02174965 - Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene N/A
Completed NCT01506024 - Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results N/A
Active, not recruiting NCT04070027 - Progressive Resistance Training Versus Total Hip Arthroplasty in Patients With Hip Osteoarthritis N/A
Withdrawn NCT04421196 - Opioid-free Total Hip Arthroplasty N/A
Not yet recruiting NCT05960903 - Patient Satisfaction After Primary THA In Assiut University
Completed NCT04084704 - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis N/A
Not yet recruiting NCT04018690 - Project Arthritis Recovering Quality of Life Through Education - Hip N/A
Completed NCT03648060 - Efficacy of a Digital Biofeedback System for Home-based Rehabilitation After Total Joint Replacement N/A
Recruiting NCT05497349 - Use of Leukocyte-Rich PRP or Leukocyte-Free PRP in the Treatment of Hip Osteoarthritis N/A
Active, not recruiting NCT04879732 - RSA - ACTIS Hip Stem N/A
Active, not recruiting NCT05142462 - Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Recruiting NCT04665908 - PT-led Triage for Patients With Hip o Knee Osteoarthritis N/A
Completed NCT04648956 - Arabic Version of the ICOAP Questionnaire
Recruiting NCT05465096 - Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells. N/A
Completed NCT02884531 - Patient Education and Basic Body Awareness Therapy in Hip Osteoarthritis: a Randomized Controlled Trial N/A
Completed NCT03031314 - Comparison of Knotless Barbed Suture and Standard Suture in Knee Replacement Patients N/A